Search

Author/Creator Neuber, Brigitte

1. Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. Issue 2 (28th July 2020)

Authors:
Fan, Fuli; Yoo, Hyeon Joo; Stock, Sophia; Wang, Lei; Liu, Yibin; Schubert, Maria‐Luisa; Wang, Sanmei; Neuber, Brigitte; Hückelhoven‐Krauss, Angela; Gern, Ulrike; Schmitt, Anita; Müller‐Tidow, Carsten; Dreger, Peter; Schmitt, Michael; Sellner, Leopold
Journal:
International journal of cancer
Issue:
Volume 148:Issue 2(2021)
Page Start:
419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients. Issue 5 (28th February 2019)

Authors:
Stock, Sophia; Übelhart, Rudolf; Schubert, Maria‐Luisa; Fan, Fuli; He, Bailin; Hoffmann, Jean‐Marc; Wang, Lei; Wang, Sanmei; Gong, Wenjie; Neuber, Brigitte; Hückelhoven‐Krauss, Angela; Gern, Ulrike; Christ, Christiane; Hexel, Monika; Schmitt, Anita; Schmidt, Patrick; Krauss, Jürgen; Jäger, Dirk; ...
Journal:
International journal of cancer
Issue:
Volume 145:Issue 5(2019)
Page Start:
1312
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. Issue 11 (11th November 2022)

Authors:
Morath, Christian; Schmitt, Anita; Schmitt, Michael; Wang, Lei; Kleist, Christian; Opelz, Gerhard; Süsal, Caner; Tran, T. Hien; Scherer, Sabine; Schwenger, Vedat; Kemmner, Stephan; Fischereder, Michael; Stangl, Manfred; Hauser, Ingeborg A.; Sommerer, Claudia; Nusshag, Christian; Kälble, Florian; ...
Journal:
BMJ open
Issue:
Volume 12:Issue 11(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro. (3rd May 2016)

Authors:
Krämer, Isabelle; Engelhardt, Melanie; Fichtner, Sabrina; Neuber, Brigitte; Medenhoff, Sergej; Bertsch, Uta; Hillengass, Jens; Raab, Marc-Steffen; Hose, Dirk; Ho, Anthony D.; Goldschmidt, Hartmut; Hundemer, Michael
Journal:
Oncoimmunology
Issue:
Volume 5:Number 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma. Issue 5 (20th April 2018)

Authors:
Kriegsmann, Katharina; Dittrich, Tobias; Neuber, Brigitte; Awwad, Mohamed H. S.; Hegenbart, Ute; Goldschmidt, Hartmut; Hillengass, Jens; Hose, Dirk; Seckinger, Anja; Müller‐Tidow, Carsten; Ho, Anthony D.; Schönland, Stefan; Hundemer, Michael
Journal:
Cytometry
Issue:
Volume 94:Issue 5(2018)
Page Start:
767
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol. Issue 5 (19th May 2019)

Authors:
Schubert, Maria-Luisa; Schmitt, Anita; Sellner, Leopold; Neuber, Brigitte; Kunz, Joachim; Wuchter, Patrick; Kunz, Alexander; Gern, Ulrike; Michels, Birgit; Hofmann, Susanne; Hückelhoven-Krauss, Angela; Kulozik, Andreas; Ho, Anthony D.; Müller-Tidow, Carsten; Dreger, Peter; Schmitt, Michael
Journal:
BMJ open
Issue:
Volume 9:Issue 5(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗